hpvac (AstraZeneca ltd)
90
Structured Review
AstraZeneca ltd
hpvac
Hpvac, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpvac/hpvac/pmc11929522-202-14-12
Average 90 stars, based on 1 article reviews
Hpvac, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpvac/hpvac/pmc11929522-202-14-12
Average 90 stars, based on 1 article reviews
hpvac - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Eosinophils and COVID-19: Insights into immune complexity and vaccine safety. Article Snippet: JV reports speaker and consultancy fees in the past 5 years from Article Title: Monkeypox 2024 outbreak: Fifty essential questions and answers. Article Snippet: JV reports speaker and consultancy fees in the past 5 years from Article Title: Editorial: In vitro diagnosis of allergic and mast cell-mediated disorders Article Snippet: JV reports speaker and consultancy fees in the past 5 years from Article Title: Allergic bronchopulmonary aspergillosis: A multidisciplinary review. Article Snippet: Allergic bronchopulmonary aspergillosis (ABPA) is a rare disease characterized by a complex allergic inflammatory reaction of airways against Aspergillus affecting patients with chronic respiratory diseases (asthma, cystic fibrosis).. Exacerbation is often the way to diagnose ABPA and marks its evolution by its recurrent character leading to cortico-requirement or long-term antifungal treatment.. Early diagnosis allows treatment of ABPA at an initial stage, preventing recurrence of exacerbations and long-term complications, mainly represented by bronchiectasis. Article Title: Pesticides as an overlooked exposomic association in allergic asthma exacerbations: A nationwide database study Article Snippet: JV reports speaker and consultancy fees in the past 5 years from Article Title: Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety Article Snippet: JV reports speaker and consultancy fees in the past 5 years from |